Moreover, troglitazone-induced PPARγ activation was shown to phosphorylate extracellular-signal-regulated kinase (ERK1/2), leading to mitochondrial-dependent apoptosis in NCI-H23 lung cancer cells. Here, PPARG is linked to lung cancer.